PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Rufinamide Tablets USP | 200mg |
![]() |
120 |
68180-804-16 |
Banzel® |
AB |
Anticonvulsants |
Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
![]() |
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
Lurasidone Hydrochloride Tablets | 20mg |
![]() |
30 |
68180-671-06 |
Latuda® |
AB |
Atypical antipsychotics |
Darunavir Tablets | 600mg |
![]() |
30 |
68180-345-07 |
Prezista® |
AB |
Antiretrovirals |
Rufinamide Oral Suspension | 40 mg/mL |
![]() |
460ml |
68180-797-01 |
Banzel® |
AB |
Antiepileptic |
Tiotropium Bromide Inhalation Powder Capsules | 18mcg / capsules |
![]() |
30 |
68180-964-12 |
Spiriva® HandiHaler® |
AB |
Anticholinergics |
Turqozâ„¢ | 0.3mg/0.03mg |
![]() |
28 x 3 |
68180-895-13 |
Lo/Ovral-28® |
AB |
Oral Contraceptives |
Diazepam Rectal Gel | 10 mg & 20 mg |
![]() |
4.4 cm & 6.0 cm |
43386-280-01 |
|||
Bromfenac Ophthalmic Solution 0.07% | 0.07% |
![]() |
3mL |
68180-433-02 |
Prolensa® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
Varenicline Tartrate Tablets | 0.5mg-1.0mg |
![]() |
53 |
70748-128-49 |
Chantix® |
AB |
Smoking Cessation Aids |
Cyanocobalamin Nasal Spray | 500mcg/ spray |
![]() |
4 UD |
43386-237-70 |
Nascobal® |
AB |
B12 Vitamins |
Ganirelix Acetate Injection | 250mcg/0.5mL |
![]() |
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
Bromfenac Ophthalmic Solution 0.075% | 0.075% |
![]() |
5ml |
68180-434-01 |
Bromsite® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
Bromfenac Ophthalmic Solution 0.09% | 0.09% |
![]() |
1.7mL |
68180-436-01 |
Bromday® |
AT2 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
Doxycycline Capsules | 40mg |
![]() |
30 |
70748-308-06 |
Oracea® |
AB |
Antibiotic |
Mirabegron Extended-Release Tablets | 25mg |
![]() |
30 |
68180-151-09 |
Myrbetriq® |
– |
Beta-3 Adrenergic Agonist |
Doxycycline for Injection USP | 100mg/ vial |
![]() |
(10) single-dose vials |
70748-338-10 |
Vibramycin® |
AP |
Tetracycline Antibiotics |
GaviLyteâ„¢-N | 420-111.20-1.48-5.72 gm |
![]() |
4 L |
43386-050-19 |
NuLYTELY® |
AA |
Hyperosmotic |
DOXOrubicin Hydrochloride Liposome Injection | 20mg/10mL (2mg/mL) |
![]() |
(1) 25mL single-dose vial |
70748-340-01 |
Doxil® |
AB |
Chemotherapeutic Agents |
Prednisolone Acetate Ophthalmic Suspension USP | 1% |
![]() |
5ml |
70748-332-03 |
Pred Forteâ„¢ |
AB |
Ophthalmic Anti-Inflammatory Corticosteroid |
Bumetanide Injection USP | 1mg/4mL (0.25mg/mL) |
![]() |
(10) 10mL multiple-dose vial |
70748-323-11 |
Bumex® |
AP |
Loop Diurectic |
Betamethasone Ointment | 0.05% |
![]() |
50g |
68180-0947-02 |
Diprolene® |
AB |
Anti-inflammatory |
Minzoyaâ„¢ Tablets | 0.1mg/0.02mg |
![]() |
28 x 3 |
70748-322-14 |
Balcoltra® |
AB3 |
Oral Contraceptives |
Rivaroxaban Tablets USP | 2.5mg |
![]() |
30 |
68180-709-09 |
Xarelto® |
AP |
Anticoagulants |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.